Remicade (infliximab) - Merck (MSD), Mitsubishi Tanabe, J&J
hydroxychloroquine - Generic mfg.
vobarilizumab (ALX-0061) - Sanofi
tacrolimus intravenous - Generic mfg.
Cimzia (certolizumab pegol) - Astellas, UCB
Rituxan (rituximab) - Biogen, Zenyaku Kogyo, Roche
CNTO6785 - J&J, Fontacea
Humira (adalimumab) - Eisai, AbbVie
tregalizumab (BT-061) - ADMA Biologics, T-Balance Therapeutics
Tremfya (guselkumab) - J&J
lanraplenib (GS-9876) - Gilead, Galapagos, Kronos Bio
decernotinib (VX-509) - Vertex
Xeljanz (tofacitinib) - Pfizer
methotrexate - Generic mfg.
Cosentyx (secukinumab) - Novartis
remtolumab (ABT-122) - AbbVie
sulfasalazine - Generic mfg.
Stelara (ustekinumab) - J&J
Jyseleca (filgotinib) - Gilead
Plivensia (sirukumab) - J&J
leflunomide - Generic mfg.
Smyraf (peficitinib) - Astellas, Maruho
PF-5230895 - Emergent Biosolutions, Pfizer
Simponi (golimumab) - Merck (MSD), Mitsubishi Tanabe, J&J
Rinvoq (upadacitinib) - AbbVie
olokizumab (CDP-6038) - R-Pharm
mavrilimumab (KPL-301) - Kiniksa
Actemra IV (tocilizumab) - Roche, JW Pharma
Olumiant (baricitinib) - Incyte, Eli Lilly
Orencia (abatacept) - BMS
Enbrel (etanercept) - Pfizer, Amgen
otilimab (GSK3196165) - GSK
Kevzara (sarilumab) - Asahi Kasei, Regeneron, Sanofi
http://www.ncbi.nlm.nih.gov/pubmed/32033937
 
Feb 10, 2020
 
Prev Next